Efficacy of Rapamycin for Refractory Hemangioendotheliomas in Maffucci's Syndrome

被引:24
作者
Riou, Stephanie [1 ]
Morelon, Emmanuel [2 ]
Guibaud, Laurent [3 ,4 ]
Chotel, Franck [3 ,4 ]
Dijoud, Frederique [3 ,4 ]
Marec-Berard, Perrine [1 ]
机构
[1] Inst Hematol Oncol Pediat, Lyon, France
[2] Univ Lyon, Hosp Civils Lyon, Hop Edouard Herriot,Lab Immun Infect & Vaccinat, INSERM,Natl Inst Hlth & Med Res,U851, Lyon, France
[3] Univ Lyon 1, F-69365 Lyon, France
[4] Hop Femme Mere Enfant, Bron, France
关键词
CANCER-THERAPY; PATHWAY; ANTIANGIOGENESIS; VINBLASTINE; SIROLIMUS; INSIGHTS; AGENTS; TARGET;
D O I
10.1200/JCO.2012.41.7287
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:E213 / E215
页数:3
相关论文
共 22 条
[21]   Antiangiogenesis is produced by nontoxic doses of vinblastine [J].
Vacca, A ;
Iurlaro, M ;
Ribatti, D ;
Minischetti, M ;
Nico, B ;
Ria, R ;
Pellegrino, A ;
Dammacco, F .
BLOOD, 1999, 94 (12) :4143-4155
[22]  
Wassef M, 2006, Ann Chir Plast Esthet, V51, P263, DOI 10.1016/j.anplas.2006.07.017